Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company sells energy storage systems and fittings, as well as valve or spare part; and manufactures various products, such as portable valve grinding equipment, electric steam boilers, customized steam systems, molds, tool… Read more
Natus Medical Incorporated (NM4) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 3.682x
Based on the latest financial reports, Natus Medical Incorporated (NM4) has a cash flow conversion efficiency ratio of 3.682x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-26.24 Million) by net assets (€-7.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Natus Medical Incorporated - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Natus Medical Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Natus Medical Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Natus Medical Incorporated ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Adgar Investments and Development Ltd
TA:ADGR
|
0.019x |
|
Pasdec Holdings Bhd
KLSE:6912
|
-0.022x |
|
Tongda Group Holdings Limited
F:TJC
|
0.055x |
|
AXMIN Inc
PINK:AXMIF
|
-0.008x |
|
UV GERMI S.A. EO -15
F:1NY
|
N/A |
|
MANTLE MINERALS
F:MXB0
|
N/A |
|
Welsis Corp.
OTCGREY:WLSS
|
0.019x |
|
Marley Spoon Group SE
XETRA:MS1
|
-0.030x |
Annual Cash Flow Conversion Efficiency for Natus Medical Incorporated (2014–2024)
The table below shows the annual cash flow conversion efficiency of Natus Medical Incorporated from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €17.75 Million | €1.47 Million | 0.083x | -13.97% |
| 2023-12-31 | €86.54 Million | €8.34 Million | 0.096x | -33.67% |
| 2022-12-31 | €56.82 Million | €8.26 Million | 0.145x | -3.52% |
| 2021-12-31 | €424.75 Million | €63.99 Million | 0.151x | +79.91% |
| 2020-12-31 | €411.09 Million | €34.43 Million | 0.084x | -41.98% |
| 2019-12-31 | €416.12 Million | €60.06 Million | 0.144x | +74.16% |
| 2018-12-31 | €398.44 Million | €33.02 Million | 0.083x | +77.33% |
| 2017-12-31 | €422.10 Million | €19.73 Million | 0.047x | -73.17% |
| 2016-12-31 | €417.37 Million | €72.69 Million | 0.174x | +84.64% |
| 2015-12-31 | €390.71 Million | €36.85 Million | 0.094x | -21.06% |
| 2014-12-31 | €352.71 Million | €42.14 Million | 0.119x | -- |